EHS
EHS

New patent for Nalpropion drug CONTRAVE – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent for Nalpropion drug CONTRAVE


Annual Drug Patent Expirations for CONTRAVE

Contrave is a drug marketed by Nalpropion and is included in one NDA. It is available from three suppliers. There are nineteen patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for CONTRAVE.

This drug has two hundred and eighteen patent family members in forty-one countries.

The generic ingredient in CONTRAVE is bupropion hydrochloride; naltrexone hydrochloride. Three suppliers are listed for this compound. Additional details are available on the bupropion hydrochloride; naltrexone hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Nalpropion drug CONTRAVE



Source link

EHS
Back to top button